Literature DB >> 19802879

Prospective study of peripheral neuropathy in Machado-Joseph disease.

Marcondes C França1, Anelyssa D'abreu, Anamarli Nucci, Fernando Cendes, Iscia Lopes-Cendes.   

Abstract

Peripheral neuropathy (PN) has long been recognized in Machado-Joseph disease (MJD), but its natural history is an unsettled issue. Therefore, we prospectively assessed 40 with MJD for 13 months with nerve conduction (NC) studies and the revised total neuropathy score (TNSr) to study the progression of PN. There was no significant change in the TNSr score over the follow-up period. In contrast, the average sural sensory nerve action potential (SNAP) amplitude decreased significantly over the same interval from a mean of 13.2 muV to 9.8 muV (P < 0.001). There was an inverse correlation between the change in the sural SNAP amplitude and the length of the CAG triplet repeat expansion (r = 0.574, P < 0.001). The reduction in the mean sural SNAP amplitude also correlated with progression of ataxia. This indicates that PN progresses faster in individuals with larger (CAG)(n) expansions, and nerve conduction studies may be useful to study disease progression in MJD.

Entities:  

Mesh:

Year:  2009        PMID: 19802879     DOI: 10.1002/mus.21396

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Administration of vincristine in a patient with Machado-Joseph disease.

Authors:  Anna Colpo; Frederick H Wilson; Valentina Nardi; Ephraim Hochberg
Journal:  Oncology       Date:  2012-03-15       Impact factor: 2.935

2.  Spinal cord damage in Machado-Joseph disease.

Authors:  Camila N Fahl; Lucas Melo T Branco; Felipe P G Bergo; Anelyssa D'Abreu; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

3.  Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Alberto R M Martinez; Marcelo B Nunes; Ingrid Faber; Anelyssa D'Abreu; Íscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

4.  Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment.

Authors:  Marcio Luiz Escorcio Bezerra; José Luiz Pedroso; Pedro Braga-Neto; Agessandro Abrahao; Marcus Vinicius Cristino de Albuquerque; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Nadia Iandoli de Oliveira Braga; Gilberto Mastrocola Manzano; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

5.  State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change.

Authors:  Gabriel Vasata Furtado; Camila Maria de Oliveira; Gabriela Bolzan; Jonas Alex Morales Saute; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Genet Mol Biol       Date:  2019-06-10       Impact factor: 1.771

Review 6.  Deubiquitinases in Neurodegeneration.

Authors:  Abudu I Bello; Rituparna Goswami; Shelby L Brown; Kara Costanzo; Taylor Shores; Shefaa Allan; Revan Odah; Ryan D Mohan
Journal:  Cells       Date:  2022-02-05       Impact factor: 6.600

7.  Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.

Authors:  Yanetza González-Zaldívar; Yaimeé Vázquez-Mojena; José M Laffita-Mesa; Luis E Almaguer-Mederos; Roberto Rodríguez-Labrada; Gilberto Sánchez-Cruz; Raúl Aguilera-Rodríguez; Tania Cruz-Mariño; Nalia Canales-Ochoa; Patrick MacLeod; Luis Velázquez-Pérez
Journal:  Cerebellum Ataxias       Date:  2015-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.